Octave Strengthens Clinical Expertise in MS and Neurodegenerative Disease – Read the Release

Investigation of Serum Based Proteomic Biomarker Signatures Relative to Steroid Responsiveness and Disease Activity Status in Relapsing Multiple Sclerosis Patients